Group schema therapy for cluster-C personality disorders A multicentre open pilot study

Open Access
Authors
  • C. van den Hengel
  • S. Hudepohl
  • L. Kunst
  • H. de Lange
  • M.A. Louter
  • S.J.M.A. Matthijssen
  • A. Schaling
  • S. Walhout
  • K.R. Wichers
  • A. Arntz
Publication date 2023
Journal Clinical Psychology and Psychotherapy
Volume | Issue number 30 | 6
Pages (from-to) 1279-1302
Organisations
  • Faculty of Social and Behavioural Sciences (FMG) - Psychology Research Institute (PsyRes)
Abstract

Background: Group schema therapy (GST) is increasingly popular as a treatment for personality disorders (PDs), including Cluster-C PDs. Individual ST has proven to be effective for Cluster-C PD patients, while the evidence for GST is limited. This study aimed to investigate the effectiveness of GST for Cluster-C PD. Moreover, differences between the specific Cluster-C PDs (avoidant PD, dependent PD and obsessive-compulsive PD) were explored. 

Methods: A multicentre open trial was conducted, including 137 patients with a Cluster-C PD (avoidant PD: n = 107, dependent PD: n = 11 and obsessive-compulsive PD: n = 19). Patients received 30 weekly GST sessions with a maximum of 180 min of individual ST and five optional monthly booster sessions. Outcome measures including Cluster-C PD severity, general psychopathological symptoms, quality of life, functional impairment, happiness, PD-related beliefs, self-esteem, self-ideal discrepancy, schemas and schema modes were assessed at baseline until 2-year follow-up with semi-structured interviews and self-report measures. Change over time and differences between the specific Cluster-C PDs were analysed with mixed regression analyses. 

Results: The outcome measures showed significant improvements for all Cluster-C PDs, with medium to large effect sizes after 2 years. A treatment dropout rate of 11.7% was found. There were some indications for differences between the Cluster-C PDs in severity at baseline, change trajectories and effectiveness of GST. 

Conclusions: This study demonstrated that GST is a promising treatment for Cluster-C PDs. The following step is a randomized controlled trial to further document the (cost-)effectiveness of GST.

Document type Article
Language English
Published at https://doi.org/10.1002/cpp.2903
Other links https://www.scopus.com/pages/publications/85170552066
Downloads
Permalink to this page
Back